RuiXiao Li, JianXin Ni, Xuelian Li, Bin Wu, Bo Li, RuiPing Su, Song Xue, YongPan An, GuoJun Wu
{"title":"“SHURUI”单端口机器人辅助肾盂成形术治疗输尿管骨盆连接处梗阻后的功能结果：单中心经验","authors":"RuiXiao Li, JianXin Ni, Xuelian Li, Bin Wu, Bo Li, RuiPing Su, Song Xue, YongPan An, GuoJun Wu","doi":"10.1002/rcs.70056","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>To explore the preliminary safety and efficacy of domestic single-port robot-assisted pyeloplasty in ureteropelvic junction obstruction.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Data from patients undergoing single-port robotic-assisted pyeloplasty (November 2023—May 2024) using the ‘SHURUI’ SP system through a single-site approach were reviewed. Details included patient demographics, intraoperative and postoperative data, and surgical outcomes.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The study included 20 patients, ages 13–39, with a male-to-female ratio of 4:1. Clinical presentations:abdominal pain (7cases), infection (2cases), and asymptomatic (11cases). All surgeries were successful, with an average operation time of 147(IQR, 125–175) minutes, blood loss of 35(IQR, 30–60) mL, and a hospital stay of 5(IQR, 3–6)days. The ureteral stent was removed 6–8 weeks post-surgery, with a subsequent CT scan at 4 months showing 100% success based on pain and obstruction resolution.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The ‘SHURUI’ single-port robotic-assisted pyeloplasty is a safe and feasible treatment for UPJO in both adults and paediatric patients.</p>\n </section>\n </div>","PeriodicalId":50311,"journal":{"name":"International Journal of Medical Robotics and Computer Assisted Surgery","volume":"21 2","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rcs.70056","citationCount":"0","resultStr":"{\"title\":\"Functional Outcomes After ‘SHURUI’ Single-Port Robot-Assisted Pyeloplasty for Uretero Pelvic Junction Obstruction: Single-Centre Experience\",\"authors\":\"RuiXiao Li, JianXin Ni, Xuelian Li, Bin Wu, Bo Li, RuiPing Su, Song Xue, YongPan An, GuoJun Wu\",\"doi\":\"10.1002/rcs.70056\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>To explore the preliminary safety and efficacy of domestic single-port robot-assisted pyeloplasty in ureteropelvic junction obstruction.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Data from patients undergoing single-port robotic-assisted pyeloplasty (November 2023—May 2024) using the ‘SHURUI’ SP system through a single-site approach were reviewed. Details included patient demographics, intraoperative and postoperative data, and surgical outcomes.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>The study included 20 patients, ages 13–39, with a male-to-female ratio of 4:1. Clinical presentations:abdominal pain (7cases), infection (2cases), and asymptomatic (11cases). All surgeries were successful, with an average operation time of 147(IQR, 125–175) minutes, blood loss of 35(IQR, 30–60) mL, and a hospital stay of 5(IQR, 3–6)days. The ureteral stent was removed 6–8 weeks post-surgery, with a subsequent CT scan at 4 months showing 100% success based on pain and obstruction resolution.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>The ‘SHURUI’ single-port robotic-assisted pyeloplasty is a safe and feasible treatment for UPJO in both adults and paediatric patients.</p>\\n </section>\\n </div>\",\"PeriodicalId\":50311,\"journal\":{\"name\":\"International Journal of Medical Robotics and Computer Assisted Surgery\",\"volume\":\"21 2\",\"pages\":\"\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-03-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rcs.70056\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Medical Robotics and Computer Assisted Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/rcs.70056\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Robotics and Computer Assisted Surgery","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/rcs.70056","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
Functional Outcomes After ‘SHURUI’ Single-Port Robot-Assisted Pyeloplasty for Uretero Pelvic Junction Obstruction: Single-Centre Experience
Background
To explore the preliminary safety and efficacy of domestic single-port robot-assisted pyeloplasty in ureteropelvic junction obstruction.
Methods
Data from patients undergoing single-port robotic-assisted pyeloplasty (November 2023—May 2024) using the ‘SHURUI’ SP system through a single-site approach were reviewed. Details included patient demographics, intraoperative and postoperative data, and surgical outcomes.
Results
The study included 20 patients, ages 13–39, with a male-to-female ratio of 4:1. Clinical presentations:abdominal pain (7cases), infection (2cases), and asymptomatic (11cases). All surgeries were successful, with an average operation time of 147(IQR, 125–175) minutes, blood loss of 35(IQR, 30–60) mL, and a hospital stay of 5(IQR, 3–6)days. The ureteral stent was removed 6–8 weeks post-surgery, with a subsequent CT scan at 4 months showing 100% success based on pain and obstruction resolution.
Conclusion
The ‘SHURUI’ single-port robotic-assisted pyeloplasty is a safe and feasible treatment for UPJO in both adults and paediatric patients.
期刊介绍：
The International Journal of Medical Robotics and Computer Assisted Surgery provides a cross-disciplinary platform for presenting the latest developments in robotics and computer assisted technologies for medical applications. The journal publishes cutting-edge papers and expert reviews, complemented by commentaries, correspondence and conference highlights that stimulate discussion and exchange of ideas. Areas of interest include robotic surgery aids and systems, operative planning tools, medical imaging and visualisation, simulation and navigation, virtual reality, intuitive command and control systems, haptics and sensor technologies. In addition to research and surgical planning studies, the journal welcomes papers detailing clinical trials and applications of computer-assisted workflows and robotic systems in neurosurgery, urology, paediatric, orthopaedic, craniofacial, cardiovascular, thoraco-abdominal, musculoskeletal and visceral surgery. Articles providing critical analysis of clinical trials, assessment of the benefits and risks of the application of these technologies, commenting on ease of use, or addressing surgical education and training issues are also encouraged. The journal aims to foster a community that encompasses medical practitioners, researchers, and engineers and computer scientists developing robotic systems and computational tools in academic and commercial environments, with the intention of promoting and developing these exciting areas of medical technology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
